You searched for "device"

1265 results found

Bone bridge conduction device for patients with bilateral microtia-atresia.

Management of microtia-atresia requires a multidisciplinary approach. Children normally require bone conduction hearing aid devices very early in life to improve and facilitate speech and language development. At a later stage, when the cranial bones have strengthened and become thicker,...

FDA grants Lenire tinnitus treatment device De Novo approval

Neuromod Devices Ltd. is proud to announce that the US Food and Drug Administration (FDA) has granted De Novo approval to Lenire.

Increasing tongue strength to reduce dysphagia: what is the potential benefit of a device driven exercise?

Weakness in tongue muscle strength and laryngeal elevation is known to have an adverse impact on swallowing function. Various swallowing exercises are often recommended to improve function of these important structures with the goal of preventing aspiration and improving swallow...

Controlled clinical trial results for FDA-approved tinnitus treatment device Lenire published in Nature Communications

Nature Communications has published the peer-reviewed results of Neuromod Devices’ TENT-A3 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A3) clinical trial for the first and only FDA-approved bimodal tinnitus treatment device, Lenire.

Meet the Johns Hopkins team developing a 3D-printed device allowing COVID-19 patients to share ventilators

    Amid a shortage of ventilators, the team of engineers and clinicians came together to create an open-source ventilator splitter that hospitals and communities can produce. CLICK HERE

New Procedure to Revolutionise Paediatric Ear Surgery Performed for the First Time using AventaMed Solo + Tympanostomy Tube Device (TTD)

AventaMed DAC, a Cork, Ireland company announced the first use of its Solo+ TTD in a paediatric patient while the patient was awake.

Cochlear implanted children are more likely to have device failure if their balance function is impaired

We know that children with permanent hearing loss are more likely to have an associated balance problem. It is also thought that children with cochlear implants (CI) that fail do so because of an increased risk of falls and head...

The EU Medical Device Regulation (MDR)

Back in May 2017, the EU Medical Device Regulation (MDR 2017/745) entered into force, replacing existing directives: Active Implantable Medical Devices (AIMD) In-vitro Diagnostic Directive (IVDD) Medical Device Directive (MDD) By 26 May 2020, the new regulation will have completed...

Controlling tinnitus

The absence of sufficient evidence for the use of integrated sound generators for the management of tinnitus led the authors to conduct a randomised blind clinical trial in which they compared the use of a conventional hearing aid with a...

Learning from reimplantation

The Irish implant centre in Dublin undertook a retrospective study of their reimplantation cases to look at what lessons could be learnt. Device failures fall into two classes: hard and soft failures. Hard failures are implant malfunction or altered performance....

International consensus paper on implantable devices for conductive or mixed loss

This is a weighty but insightful ‘Special Feature’ paper in the June edition of Otology and Neurotology. It has the broad aim to gather current opinion from otologists, audiologists, manufacturers and health-economists from around the world on unilateral hearing implantation...

Early results of the Cochlear Osia (active transcutaneous bone-conduction implant) in teenagers

This funded research trial involving 14 adolescents, aged 10 to 17 years, in the Toronto Hospital for Sick Kids was carried out just prior to the new Osia implant obtaining FDA approval for use in the USA. The majority had...